Author
Listed:
- Kazzem Gheybi
(University of Sydney)
- Pamela X. Y. Soh
(University of Sydney)
- Jue Jiang
(University of Sydney)
- Tumisang M. N. Mbeki
(University of Pretoria)
- Melanie Louw
(National Health Laboratory Services
University of the Witwatersrand)
- Daniel Burns
(The Institute of Cancer Research)
- Piyushkumar Mundra
(University of New South Wales Sydney)
- Daria Kiriy
(University of Copenhagen)
- Md. Mehedi Hasan
(University of Sydney)
- Weerachai Jaratlerdsiri
(University of Sydney
University of Sydney)
- Maphuti Tebogo Lebelo
(University of Pretoria)
- Raymond A. Campbell
(University of Pretoria)
- Mulalo B. Radzuma
(Medunsa)
- Mukudeni Nenzhelele
(Shayandima)
- Muvhulawa Obida
(University of Pretoria
Shayandima)
- Martin Obida
(University of Pretoria
Shayandima)
- Winstar M. Ombuki
(University of Nairobi)
- Micah O. Oyaro
(University of Nairobi)
- Sean M. Patrick
(University of Pretoria)
- Massimo Loda
(Weil Cornell Medicine)
- David C. Wedge
(University of Manchester)
- Robert G. Bristow
(University of Manchester)
- Daniel S. Brewer
(University of East Anglia
Norwich Research Park)
- Colin S. Cooper
(The Institute of Cancer Research
University of East Anglia)
- Jüri Reimand
(Ontario Institute for Cancer Research
University of Toronto)
- Geraldine Cancel-Tassin
(Hospital Tenon
Tenon Hospital)
- Olivier Cussenot
(Hospital Tenon
Tenon Hospital)
- Chris M. Hovens
(The Victorian Comprehensive Cancer Centre
Melbourne
The University of Melbourne)
- Niall M. Cocoran
(The Victorian Comprehensive Cancer Centre
Melbourne
The University of Melbourne)
- Phillip D. Stricker
(St Vincent’s Prostate Cancer Research Centre)
- Thorsten Schlomm
(Charité Universitätsmedizin Berlin)
- Gail S. Prins
(University of Illinois at Chicago)
- Karina Dalsgaard Sørensen
(Aarhus University Hospital
Aarhus University)
- Joachim Weischenfeldt
(University of Copenhagen
Charité Universitätsmedizin Berlin)
- Shingai B. A. Mutambirwa
(Medunsa)
- Peter M. Ngugi
(University of Nairobi)
- David M. Thomas
(University of New South Wales Sydney)
- Zsofia Kote-Jarai
(The Institute of Cancer Research)
- Rosalind A. Eeles
(The Institute of Cancer Research
The Royal Marsden NHS Foundation Trust London)
- M. S. Riana Bornman
(University of Pretoria)
- Vanessa M. Hayes
(University of Sydney
University of Pretoria
University of Manchester
University of East Anglia)
Abstract
Prostate cancer (PCa) germline testing, while gaining momentum, is ancestry restrictive and African exclusive. Through whole genome sequencing for 217 African ancestral cases (186 southern African, 31 Pan representative), we identify 172 potentially pathogenic variants in 78 DNA damage repair or PCa related genes. Prevalence for reported (13/217, 5.99%) and cumulative predicted (24/217, 11.06%) variants of significance (11 genes) falls below that reported for non-Africans. Conversely, BRCA1, HOXB13, CDK12, MLH1, MSH2, and BRIP1 remain unimpacted. Through pathogenic ranking based on variant frequency and functionality, clinical presentation and tumour-matched biallelic inactivation, top-ranked candidates include PREX2, POLE, FAT1, BRCA2, POLQ, LRP1B and ATM. Besides notable impact of DNA polymerases, including POLG, Fanconi anaemia genes include FANCD2, FANCA, FANCG, ERCC4, FANCE and FANCI, while DNA mismatch repair genes MSH3 and PMS1 outranked known namesakes MSH6 and PMS2. This study provides insights into the spectrum of African-relevant potentially pathogenic PCa variants, highlighting much-needed gene candidates for ancestry-inclusive germline testing.
Suggested Citation
Kazzem Gheybi & Pamela X. Y. Soh & Jue Jiang & Tumisang M. N. Mbeki & Melanie Louw & Daniel Burns & Piyushkumar Mundra & Daria Kiriy & Md. Mehedi Hasan & Weerachai Jaratlerdsiri & Maphuti Tebogo Lebel, 2025.
"Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry,"
Nature Communications, Nature, vol. 16(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-63865-6
DOI: 10.1038/s41467-025-63865-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-63865-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.